by Oleg Vishnevski | Aug 18, 2021 | News
Transformative deal significantly increases IVD development, manufacturing and sales channel for novel ELISA and Chemiluminescent immunoassay platforms August 18, 2021 7:00 AM Pacific Daylight Time South San Francisco, CA.– (BUSINESS/PR WIRE)– BioCheck,...
by Oleg Vishnevski | Apr 8, 2021 | News, Products
Parasites & Helicobacter Pylori in Egyptian Children with or without Diabetes with Gastrointestinal Manifestations & High Calprotectin Level Abstract Background and Objective This study highlighted the prevalence of parasitic infection in type-1...
by Oleg Vishnevski | Sep 30, 2020 | News, Products
Testosterone Administration During Energy Deficit Suppresses Hepcidin and Increases Iron Availability for Erythropoiesis Context: Severe energy deprivation markedly inhibits erythropoiesis by restricting iron availability for hemoglobin synthesis. Objective:...
by Oleg Vishnevski | Sep 24, 2020 | News, Products
Role of Hepcidin to Identify the Type of Anemia in Chronic Kidney Disease in Children See full study: https://iopscience.iop.org/article/10.1088/1742-6596/1246/1/012023/meta Abstract Chronic kidney disease (CKD) may present with anemia of chronic disease (ACD),...
by Oleg Vishnevski | May 15, 2020 | News
Hepcidin Proficiency Test On April 30th, 2020, we received the final report of the first ever Hepcidin Proficiency Test. This study has being organized by Radboud University Medical Center (in Nijmegen, The Netherlands) in collaboration with SKML (the Dutch Foundation...
by Oleg Vishnevski | Apr 15, 2020 | News
In Vitro Diagnostic Assays for COVID-19: Recent Advances and Emerging Trends Diagnostics (Basel). 2020 Apr 5;10(4). pii: E202. doi: 10.3390/diagnostics10040202.Pictor Private Limited, 24 Balfour Road Parnell, 1052 Auckland, New Zealand. Abstract There have been...
